add site
services
publishers
database
health videos
toolbar
stats
live show
health store
more stuff
JOIN/LOGIN
| advertise add site services publishers database health videos
| | about toolbar stats live show health store more stuff JOIN/LOGIN |
| Health World US Business Political Technology Entertainment Sports Popular |
CORRECT: (11/25) Teva Files 2nd Citizen's Petition To Block Generic CopaxoneWall Street Journal - - 8 hours ago In a document posted last week, Teva claims generic drug makers can't show their drug is a precise copy of Copaxone--a fact that should preclude market ... Ranbaxy Launches Generic Valtrex in usWall Street Journal - - 15 hours ago However, there were doubts Ranbaxy would be able to launch in time as the FDA banned it from importing more than 30 generic drugs into the US in September ... Ranbaxy launches GSK's blockbuster drug in US Business Standard Getting The Job Done Right: Strengthening The Senate Bill To Fully Protect ...Huffington Post (blog) - 21 hours ago In 2008 alone, consumers and the federal government saved over $120 billion thanks to generic drugs. Unfortunately, regulatory structure currently provides ... AMCP Posts Summary Of Key Provisions In Senate's HR 3590" Medical News Today (press release) Form 44 causing role confusion for drug controllerDaily News & Analysis - - 3 hours ago Mumbai: A December 2001 gazette notification, which introduced Form 44 in the Drugs and Cosmetics Act, is proving to be an Achilles' heel for generic drugs ... UPDATE 2-Vectura eyes Boehringer generic, H1 beats forecastReuters - - 14 hours ago Vectura has licensed out a number of developmental treatments to Novartis, including two lung drugs which are widely seen as generic versions of ... CORRECT: UPDATE: Vectura, Boehringer Deal Ends As Loss Narrows Wall Street Journal Vectura First-half Loss Narrows As Novartis Readies Trial Wall Street Journal Pfizer reportedly to sell generic drugs in JapanMarketWatch - Nov 18, 2009 By MarketWatch TOKYO (MarketWatch) -- Pfizer Inc. plans to release generic drugs in Japan as early as 2011, expecting demand to increase as industrialized ... Pfizer's Generic Growth, With a Side of Sashimi Motley Fool Medco Beats, Provides Strong Outlook - Analyst BlogBenzinga - 11 hours ago The huge acceptance of generic drugs (they have higher margins for PBMs compared to branded drugs) is evident from the fact that the generic dispensing rate ... NCKU signed a MOU with ScinoPharm Taiwan on Nov. 24th中央通訊社 - 22 hours ago A generic drug (generic drugs, short: generics) is a drug which is produced and distributed without patent protection. The generic drug may still have a ... Pfizer pins hopes on Aurobindo, does not rule out Indian buysLivemint - - Nov 26, 2009 To counter the impact of the patent expiry and competition from generic drugs, Simmons said Pfizer is implementing a three-pronged strategy to expand its ... Aurobindo hopes to become $2 billion company in 3 years Trading Markets (press release) Aurobindo's stock seems fairly valued at the current price Economic Times Bayer not ruling out large acquisitions: CEOReuters - - 14 hours ago N), for instance, generates around a quarter of its annual sales with cholesterol drug Lipitor, which will start to face US generic competition in 2011. ... | How to call the show... 1) Make sure the show is live (see graphic above). 2) Dial 724-444-7444. 3) Enter Call ID# 27566 when prompted. 4) Follow the phone prompts to join the call. Would you like to be a special guest on the show? Send us an email which includes your contact information and the topic(s) that you would like to discuss. Listen to past shows featuring special guests...  Bernard von NotHaus (Liberty Dollar)Aubrey de Grey, PhDDr. Amanuel Sima, MDDr. Bard Levey, DDSNeal AdamsRobin Scovill (director)Richard Diaz (author)Dr. Kaayla T. Daniel, CCNChana de Wolf, (cryonics researcher)Dr. Mary Ruwart (author & scientist)Richard Diaz (author)Dr. Jason Helliwell, OB/GYN |
| ↑ top of page ↑ | about thumbshots |
